WongYYvan der Vuurst de VriesRMvan PeltDet al. T-cell activation marker sCD27 is associated with clinically definite multiple sclerosis in childhood-acquired demyelinating syndromes. Mult Scler2018; 24: 1715–1724.
2.
BelmanALKruppLBOlsenCSet al. Characteristics of children and adolescents with multiple sclerosis. Pediatrics2016; 138: e20160120.
3.
GormanMPHealyBCPolgar-TurcsanyiMet al. Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis. Arch Neurol2009; 66: 54–59.
4.
KruppLBTardieuMAmatoMPet al. International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: Revisions to the 2007 definitions. Mult Scler2013; 19: 1261–1267.
5.
HeussingerNKontopantelisEGburek-AugustatJet al. Oligoclonal bands predict multiple sclerosis in children with optic neuritis. Ann Neurol2015; 77: 1076–1082.
6.
Vargas-LowyDKivisakkPGandhiRet al. Increased Th17 response to myelin peptides in pediatric MS. Clin Immunol2013; 146: 176–184.
7.
BalintBHaasJSchwarzAet al. T-cell homeostasis in pediatric multiple sclerosis: Old cells in young patients. Neurology2013; 81: 784–792.
8.
KomoriMBlakeAGreenwoodMet al. Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis. Ann Neurol2015; 78: 3–20.
9.
Van Der Vuurst De VriesRMMescheriakovaJYRuniaTFet al. Soluble CD27 levels in cerebrospinal fluid as a prognostic biomarker in clinically isolated syndrome. JAMA Neurol2017; 74: 286–292.
